Investors following the electronics space often look at different points along the same supply chain. BHE, or Benchmark Electronics, provides design and manufacturing services for complex electronic systems used in semiconductor equipment, medical devices, aerospace and defense, and advanced computing. VSH, or Vishay Intertechnology, supplies the discrete semiconductors and passive components that power those systems. Comparing the two helps traders assess how a contract manufacturer and a component supplier are each positioned amid AI infrastructure buildout, industrial recovery, and defense spending.
BHE operates as an electronics manufacturing services provider that handles engineering, design, and production throughout the product lifecycle. Its latest quarter showed revenue near $811 million, representing a 19% increase from the prior year, supported by strength in semiconductor capital equipment, advanced computing and communications, and medical programs. Management raised its full-year outlook, pointing to a solid bookings pipeline and new customer programs ramping up.
Market reaction has been mixed. The stock posted strong year-to-date gains before pulling back recently amid broader tech profit-taking and questions around its relatively modest net margins. Recent developments include a new European manufacturing partnership for tactical communications and expanded U.S. production for a cloud-platform customer. Insider selling and the retreat from the 52-week high have added some caution in the short term. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
VSH ranks among the largest makers of discrete semiconductors and passive electronic components, with exposure to automotive, industrial, aerospace and defense, and AI-related power markets. The most recent quarter delivered record revenue of roughly $979 million, up 24% year over year, accompanied by meaningful gross-margin expansion from improved pricing and product mix. The company reported a book-to-bill ratio of 1.29 and a backlog of about $2.2 billion, representing roughly 6.6 months of shipments.
Despite its strong year-to-date advance, VSH shares also eased in recent weeks as investors consider whether margin gains will hold once additional supply comes online. Under its “Vishay 3.0” initiative, the firm is expanding capacity, rebuilding distributor inventories, and broadening its customer base—steps management credits with market-share gains. This execution supports relative performance even while near-term capital spending limits free cash flow.
The fundamental difference lies in their business models. BHE is service-oriented, which keeps margins structurally lower but allows revenue to benefit from customer program ramps in high-growth areas. VSH is product-driven and enjoys greater pricing power in tight supply conditions, as seen in its improved gross margins.
On momentum, both have recorded strong year-to-date advances. VSH shows more consistent trend behavior with six straight quarters of growth, record bookings, and backlog visibility extending into 2027. BHE demonstrates solid revenue momentum but faces more scrutiny over thinner profitability and valuation following its quick rise. Risk profiles also vary: VSH contends with semiconductor cyclicality and elevated capital spending, whereas BHE is more exposed to customer concentration and program timing.
Based on the data points available, Tickeron’s AI currently leans toward VSH. Record revenue, expanding gross margins, a book-to-bill ratio well above 1.0, and a multi-quarter backlog point to a more consistent and reinforcing trend than BHE currently displays. While BHE maintains meaningful growth drivers in semiconductor capital equipment and medical programs, its narrower margins and recent pullback add relative uncertainty. VSH therefore appears the more favorable of the two at present, though these assessments remain probabilistic and can shift with evolving conditions.
In my own analysis I often turn to Tickeron’s AI Daily Buy/Sell Signals to cross-check momentum readings and see how automated strategies are positioned on names like these. The platform offers a straightforward way to review signal history and compare multiple tickers side by side, which helps keep the decision process grounded in data rather than headlines.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BHE declined for three days, in 167 of 277 cases, the price declined further within the following month. The odds of a continued downward trend are 60%.
The 10-day moving average for BHE crossed bearishly below the 50-day moving average on October 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 60%.
The 50-day moving average for BHE moved below the 200-day moving average on November 19, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Aroon Indicator for BHE entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BHE's RSI Oscillator exited the oversold zone, 15 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 36 of 48 cases where BHE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Momentum Indicator moved above the 0 level on November 19, 2026. You may want to consider a long position or call options on BHE as a result. In 65 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.
The Moving Average Convergence Divergence (MACD) for BHE just turned positive on November 19, 2026. Looking at past instances where BHE's MACD turned positive, the stock continued to rise in 40 of 53 cases over the following month. The odds of a continued upward trend are 75%.
Following a +2.62% 3-day Advance, the price is estimated to grow further. Considering data from situations where BHE advanced for three days, in 228 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
BHE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Profit vs. Risk Rating rating for this company is 41 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 52 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.944) is normal, around the industry mean (3.856). P/E Ratio (40.811) is within average values for comparable stocks, (6.228). BHE's Projected Growth (PEG Ratio) (0.010) is slightly lower than the industry average of (0.930). Dividend Yield (0.011) settles around the average of (0.021) among similar stocks. P/S Ratio (0.950) is also within normal values, averaging (4.422).
The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating steady price growth. BHE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 83 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of contract manufacturing and design services to original equipment manufacturers
Industry ElectronicComponents